Pre-Sterilized Nested Vials Market Report 2026

Pre-Sterilized Nested Vials Market Overview

• Pre-Sterilized Nested Vials market size has reached to $1.24 billion in 2025 • Expected to grow to $2.36 billion in 2030 at a compound annual growth rate (CAGR) of 13.7% • Growth Driver: Rising Biologics Adoption Driving Growth In Market Due To Enhanced Drug Safety, Reduced Preparation Time, And Improved Administration Efficiency • Market Trend: Leading Industry Players Driving Innovations In Sterile Drug Packaging And Container Integrity • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Pre-Sterilized Nested Vials Market?

Pre-sterilized nested vials are pharmaceutical packaging containers supplied in a ready-to-use sterile format, where individual vials are arranged in a nested configuration within trays or tubs. This design minimizes manual handling, reduces contamination risk, and supports automated aseptic filling processes, making them especially suitable for injectable and other sterile drug products. The main product types of pre-sterilized nested vials include glass nested vials and plastic nested vials. Glass nested vials refer to pre-sterilized containers designed to hold multiple doses of injectable drugs or biologics in a nested arrangement for efficient handling and storage. The sterilization methods include gamma sterilization, ethylene oxide sterilization, steam sterilization, and others with capacities that include 2R, 6R, 10R, 20R, and other capacities. The various applications involved are injectable drugs packaging, biologics packaging, vaccine packaging, clinical trial packaging, and aseptic fill-finish operations, and they are used by several end users such as hospitals, contract manufacturing organizations, research institutes, and other end-users.

What Is The Pre-Sterilized Nested Vials Market Growth Forecast?

The pre-sterilized nested vials market size is expected to see rapid growth in the next few years. It will grow to $2.36 billion in 2030 at a compound annual growth rate (CAGR) of 13.7%. The growth in the forecast period can be attributed to automation in aseptic fill-finish, development of eco-friendly nested vials, expansion of vaccine manufacturing, adoption of advanced polymer and glass materials, integration with digital tracking and monitoring systems. Major trends in the forecast period include automated aseptic filling integration, pre-sterilized packaging adoption, nested vial handling automation, advanced material development, regulatory compliance optimization.

Global Pre-Sterilized Nested Vials Market Segmentation

1) By Product Type: Glass Nested Vials, Plastic Nested Vials 2) By Sterilization Method: Gamma Sterilization, Ethylene Oxide Sterilization, Steam Sterilization, Other Sterilization Methods 3) By Capacity: 2R, 6R, 10R, 20R, Other Capacities 4) By Application: Injectable Drugs Packaging, Biologics Packaging, Vaccine Packaging, Clinical Trial Packaging, Aseptic Fill-Finish Operations 5) By End-User: Hospitals, Contract Manufacturing Organizations, Research Institutes, Other End-Users Subsegments: 1) By Glass Nested Vials: Type I Borosilicate, Type II Soda Lime Treated, Type III Soda Lime, Neutral Glass 2) By Plastic Nested Vials: Polypropylene, Polyethylene, Cyclo Olefin Polymer, Polycarbonate

What Is The Driver Of The Pre-Sterilized Nested Vials Market?

The rising adoption of biologics is expected to propel the growth of the pre-sterilized nested vials market. Biologics adoption refers to the increasing use of biologic therapies by healthcare providers and patients in routine clinical practice. This adoption is driven by the ability of biologics to deliver targeted therapeutic effects, particularly in the treatment of chronic, autoimmune, and metabolic diseases where conventional small-molecule therapies often show limited efficacy. Pre-sterilized nested vials support the growing use of biologics by offering ready-to-use, contamination-free primary packaging solutions that ensure product safety, preserve drug stability, and reduce preparation time during aseptic filling and administration. For instance, in October 2024, the Generics and Biosimilars Initiative (GaBI), a Belgium-based organization providing scientific information on generic and biosimilar medicines, reported that beyond the nine leading biologics, two additional complex biologic drugs-Novo Nordisk’s Ozempic (semaglutide) and Eli Lilly’s Trulicity (dulaglutide), both prescribed for type 2 diabetes—recorded significant sales in 2023, reaching approximately US$14 billion and US$7.2 billion, respectively. Therefore, the rising adoption of biologics is driving the growth of the pre-sterilized nested vials industry.

Key Players In The Global Pre-Sterilized Nested Vials Market

Major companies operating in the pre-sterilized nested vials market are Corning Incorporated, Terumo Corporation, Nipro PharmaPackaging, West Pharmaceutical Services Inc., Gerresheimer AG, Datwyler Holding Inc., Stevanato Group, SCHOTT AG, Shandong Pharmaceutical Glass Co. Ltd., SGD Pharma, Bormioli Pharma, Adelphi Healthcare Packaging, DWK Life Sciences, Linuo Glassworks Group, SiO2 Materials Science, Jinan Youlyy Industrial Co. Ltd., Origin Pharma Packaging, Pacific Vial Manufacturing Inc., Daikyo Seiko Ltd., Qorpak, AptarGroup Inc., QCVIALZ LLC.

Global Pre-Sterilized Nested Vials Market Trends and Insights

Major companies operating in the pre-sterilized nested vials market are focusing on developing innovative solutions such as, container closure integrity to ensure sterile drug delivery, prevent contamination, and maintain the stability and safety of pharmaceutical products. Container closure integrity refers to a packaging system’s ability to maintain a complete seal that prevents contamination, leakage, or loss of sterility. For instance, in May 2024, West Pharmaceutical Services Inc., a US-based manufacturing company, launched Daikyo Crystal Zenith (CZ) Nested Vials in a Tub as ready-to-use, pre-sterilized cyclic olefin polymer (COP) vials for sensitive therapies like cell/gene treatments and radiopharmaceuticals. Available in 2 mL (100 vials/tub) and 10 mL (48 vials/tub) sizes with ISO 8362-1 glass-like exterior dimensions, they ensure cryogenic container closure integrity, low particulates (<2% USP <788>), high viral vector recovery, breakage resistance, and minimal chemical interactions.

What Are Latest Mergers And Acquisitions In The Pre-Sterilized Nested Vials Market?

In August 2025, SGD Pharma, a France-based manufacturing company, acquired Alphial S.r.l. for an undisclosed amount. With this acquisition, SGD Pharma aims to accelerate its growth in the pharmaceutical packaging sector, increase operational efficiency, and deliver a broader range of specialized glass solutions to meet evolving industry demands. Alphial S.r.l. is an Italy-based manufacturing company that offers pre-sterilized, ready-to-use (RTU) vials.

Regional Insights

North America was the largest region in the pre-sterilized nested vials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Pre-Sterilized Nested Vials Market?

The pre-sterilized nested vials market consists of sales of pre-sterilized vials in cup-nest format, pre-sterilized nested vials with integrated closures, and pre-sterilized nested vial kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data And Analysis Are Included In The Pre-Sterilized Nested Vials Market Report 2026?

The pre-sterilized nested vials market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pre-sterilized nested vials industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.